Evidence map›Paper›PMID 33417620›Full record

ArticlePloS one2021

Evaluation of the national surveillance system for invasive meningococcal disease, Italy, 2015-2018.

Xanthi D Andrianou, Flavia Riccardo, Maria Grazia Caporali, Cecilia Fazio, Arianna Neri, Paola Vacca, Luigina Ambrosio, Patrizio Pezzotti, Paola Stefanelli

Abstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xanthi D AndrianouDepartment of Infectious Diseases, Italian National Institute of Health (Istituto Superiore di Sanità), Rome, Italy.
Flavia RiccardoDepartment of Infectious Diseases, Italian National Institute of Health (Istituto Superiore di Sanità), Rome, Italy.ORCID 0000-0002-1582-6329
Maria Grazia CaporaliDepartment of Infectious Diseases, Italian National Institute of Health (Istituto Superiore di Sanità), Rome, Italy.
Cecilia FazioDepartment of Infectious Diseases, Italian National Institute of Health (Istituto Superiore di Sanità), Rome, Italy.
Arianna NeriDepartment of Infectious Diseases, Italian National Institute of Health (Istituto Superiore di Sanità), Rome, Italy.
Paola VaccaDepartment of Infectious Diseases, Italian National Institute of Health (Istituto Superiore di Sanità), Rome, Italy.
Luigina AmbrosioDepartment of Infectious Diseases, Italian National Institute of Health (Istituto Superiore di Sanità), Rome, Italy.
Patrizio PezzottiDepartment of Infectious Diseases, Italian National Institute of Health (Istituto Superiore di Sanità), Rome, Italy.
Paola StefanelliDepartment of Infectious Diseases, Italian National Institute of Health (Istituto Superiore di Sanità), Rome, Italy.ORCID 0000-0003-1620-4385

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enhanced laboratory-based surveillance of invasive meningococcal disease (IMD) in Italy was only assessed indirectly by numerically comparing surveillance data cases with hospital discharge records (HDR). In this study, we evaluated the completeness, timeliness and sensitivity of the IMD surveillance in Italy from 2015 to 2018. Completeness and timeliness were described at the national and subnational level. A capture-recapture analysis was conducted to evaluate the sensitivity and positive predictive value (PPV) using HDR as the external source with a combination of deterministic and probabilistic approaches. The characteristics of the unmatched vs. matched cases were compared using multivariable Poisson modeling. Overall, the completeness of data improved, except for specific variables. Timeliness of notifications also improved to a median of 4 days from onset to reporting. For the years 2015-2017, the sensitivity of the surveillance was estimated at 71.4% and the PPV at 77.5%, changing to 80.6% and 66.9% respectively after removing cases with a secondary meningitis diagnosis. We noted substantial sub-national differences. In 2018 sensitivity was 66.5% (135/203) and the PPV was 79.4% (135/170). The adjusted relative risk of being unmatched in 2015-2017 was higher in cases that were ≥60 years, had missing information or symptom onset in December. The IMD surveillance system overall performs well with completeness and timeliness improving in time. Specific challenges identified for individual variables should guide further improvement. Notwithstanding limitations posed by the comparison database, sensitivity and PPV are promising. The study highlights that promoting etiological ascertainment in people ≥60 years and addressing sub-national challenges are the main current challenges to address.

Indexed as

Epidemiological MonitoringAdultFemaleHumansItalyMaleMeningococcal InfectionsSeverity of Illness Index

Identifiers

PMID33417620
PMCPMC7793274

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.